Deferred registration: Quotient Sciences code: QSC303996

Registry ID

ISRCTN54346737

Source registry

ISRCTN

Status

Recruiting

Phase

PHASE1

Study type

INTERVENTIONAL

Sponsor

Orion Corporation (Finland)

Enrollment

44

Start date

2026-05-15

Completion date

2026-09-23

Last update

2026-08-17

Conditions

• Other

Summary

Healthy volunteers

Detailed description

This is a phase I trial in healthy volunteers only and qualifies for an automatic deferral. The full details will be added to the trial record on or before the deferral expiry date.

Interventions

• DRUG: This is a phase I trial in healthy volunteers only and qualifies for an automatic deferral. The full details will be added to the trial record on or before the deferral expiry date.

Inclusion criteria

This is a phase I trial in healthy volunteers only and qualifies for an automatic deferral. The full details will be added to the trial record on or before the deferral expiry date.

Exclusion criteria

This is a phase I trial in healthy volunteers only and qualifies for an automatic deferral. The full details will be added to the trial record on or before the deferral expiry date.

Locations

• , , England
• , , United Kingdom

Related clinical trials

• Testing a job crafting intervention to help make work more manageable, engaging and enjoyable for UK workers
• Understanding the impact of resistant bugs on deaths in England
• Helping local authorities to help parents: the BeST Engage Project
• Copen-SCALE: Scaling up an effective intervention to childcare institutions in Copenhagen
• Understanding the impact of exposure to health and medicines misinformation on public trust in the pharmaceutical industry: a UK mixed-methods study (PHARMAFICTION)
• Helping young people to adapt their internet use and promote mental well-being in a rapidly changing world

View on source registry